SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001016169-08-000031
Filing Date
2008-05-16
Accepted
2008-05-16 16:15:31
Documents
1
Period of Report
2008-05-14

Document Format Files

Seq Description Document Type Size
1 dcarrara05152008_ex.html 4  
1 dcarrara05152008_ex.xml 4 5440
  Complete submission text file 0001016169-08-000031.txt   7683
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Issuer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10

Mailing Address C/O AMTARES PHARMA INC 707 EAGLEVIEW BLVD STE 414 EXTON PA 19341
Business Address C/O ANTARES HAMA INC 707 EAGLEVIEW BLVD STE 414 EXTON PA 19341 6104586200
CARRARA DARIO (Reporting) CIK: 0001187498 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32302 | Film No.: 08842534